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RESEARCH ARTICLE
Application of chromosomal DNA and protein targeting
for the identification of Yersinia pestis
Marilynn A. Larson1, Shi-Jian Ding1, Shawn R. Slater1, Anna Hanway1, Amanda M. Bartling1,
Paul D. Fey1, Oksana Lockridge2, Stephen C. Francesconi3 and Steven H. Hinrichs1
1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
2Eppley Institute, University of Nebraska Medical Center, Omaha, NE, USA
3Naval Medical Research Center, Frederick, MD, USA
Purpose: A comprehensive strategy was developed and validated for the identification of
pathogens from closely related near neighbors using both chromosomal and protein biomark-
ers, with emphasis on distinguishing Yersinia pestis from the ancestral bacterium Yersinia
pseudotuberculosis.
Experimental design: Computational analysis was used to discover chromosomal targets
unique to Y. pestis. Locus identifier YPO1670 was selected for further validation and PCR
was used to confirm that this biomarker was exclusively present in Y. pestis strains, while
absent in other Yersinia species. RT-PCR and Western blot analyses were utilized to evaluate
YPO1670 expression and MRMMS was performed to identify the YPO1670 protein within cell
lysates.
Results: The described study validated that YPO1670 was exclusive to Y. pestis. PCR con-
firmed the locus to be unique to Y. pestis. The associated transcript and protein were produced
throughout growth with the highest abundance occurring in stationary phase and MRM MS
conclusively identified the YPO1670 protein in cell extracts.
Conclusions and clinical relevance: These findings validated YPO1670 as a reliable candidate
biomarker for Y. pestis and that a dual DNA and protein targeting approach is feasible for
the development of next-generation assays to accurately differentiate pathogens from near
neighbors.
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1 Introduction
The single chromosomes of Yersinia pestis and Yersinia pseu-
dotuberculosis share 97% nucleotide identity and molecular
studies strongly suggest thatY. pestis emerged fromY. pseudo-
tuberculosis [1,2]. Yersinia pestis strains generally harbor three
plasmids while Y. pseudotuberculosis strains typically have
one plasmid [3]. Yersinia pseudotuberculosis is a ubiquitous
soil- and water-borne microbe capable of causing mesenteric
adenitis and septicemia [4]. In contrast, Y. pestis is a blood-
Correspondence:Dr. Steven H. Hinrichs, Department of Pathology
and Microbiology, 985900 Nebraska Medical Center, Omaha, NE
68198-5900, USA
E-mail: shinrich@unmc.edu
Fax: +1-402-559-7838
Abbreviations: BHI, brain-heart infusion; TSB, tryptic soy broth
borne pathogen that can cause life-threatening bubonic and
pulmonary plague that can be lethal within days if left un-
treated, meriting the concern that this pathogen may be used
as a biological weapon [4–7]. Bubonic plague is a zoonotic dis-
ease that can be transmitted to humans by infected animals
or insects and pulmonary plague can be transmitted from
person to person via airborne infectious particles. Plague has
been responsible for at least three pandemics and persists
today with humans and animals being infected throughout
the world [5,8,9]. Since Y. pestis is classified as a select agent,
the presumptive identification of this pathogen prompts an
investigation by public health authorities with corresponding
assessment using molecular assays.
Current DNA-based molecular assays are dependable
when used in routine clinical applications. However,
misidentification has occurred when assays were chal-
lenged with mixtures of clinical and environmental samples.
Increased specificity has resulted from the use of multiple
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.clinical.proteomics-journal.com
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genomic targets using PCR-based platforms to extend func-
tionality and confirm identity of rare organisms. Due to the
low prevalence of disease caused by Y. pestis in industrial-
ized countries, even a highly specific test generates an unac-
ceptable number of false-positive results. Further, differen-
tiation methods that focus on plasmid targets are unreliable
since plasmids can be eliminated. Therefore, next-generation
assays for the identification of infectious organisms are ex-
pected to detect multiple signatures for improved specificity,
increasing theneed for species-specific chromosomal-derived
targets.
Detection of protein mass patterns by MS has been used
to characterize pathogenic and environmental microbes in
which highly abundant proteins are predominantly repre-
sented in the peptide mass fingerprints, masking the de-
tection of unique proteins in low abundance [10]. MALDI
TOF biotyping in clinical microbiology laboratories has been
reported to rapidly identify the bacterium directly from a
single colony, but enrichment of the microbe is typically
required [10]. Although MALDI-based biotyping is fast, a
major disadvantage of this approach is the difficulty in de-
ciphering the identity of the peaks within a differential pat-
tern. Shotgun mass mapping utilizing LC MS/MS has also
been exploited to define a set of conserved bacterial pro-
teins [11, 12], but acquisition of the results requires sev-
eral days. In comparison to these approaches, MRM MS
provides both rapid and accurate identification of microbes
by detecting species-specific biomarkers, following valida-
tion of potential targets derived from genomic or proteomic
sequencing.
The goal of this project was to utilize a combinational
approach targeting both chromosomal DNA and protein
biomarkers using PCR andMRMMS, respectively, to reliably
differentiate Y. pestis from closely related microbes such as Y.
pseudotuberculosis. The study presented here validates a can-
didate Y. pestis-specific chromosomal and protein biomarker
for clinical diagnostics and environmental research, as well
as describes a comprehensive strategy that can be applied to
accurately distinguish other pathogens from near neighbors
that share considerable genomic content.
2 Materials and methods
2.1 Yersinia sp. strains and culture conditions
Yersinia pestis strains were transferred to theUniversity of Ne-
braska Medical Center in Omaha following the requirements
of the Select Agent Program as outlined in the Animal and
Plant Health Inspection Service/Centers for Disease Con-
trol and Prevention (CDC) Form 2, Guidance Document for
Request to Transfer Select Agents and Toxins [13]. Manipu-
lation of viable culture material was performed by authorized
individuals within a biosafety level 3 laboratory certified for
select agent work by the United States Department of Health
and Human Services using laboratory biosafety criteria as
described by the National Institutes of Health and CDC [14].
Prior to removal ofY. pestis cell preparations, lysate, or nucleic
acids from the biosafety level 3 facility, sterility was confirmed
by plating 10% of the sample onto sheep blood agar or choco-
late agar plates and incubating the plates for 3 days at 37C
with ambient air. Yersinia species examined in the inclusivity
and exclusivity test panels to assess specificity are shown in
Supporting Information Table S1. Confirmation of species
identity was obtained by biochemical and PCR analyses. Cul-
turing procedures are also described in the Supporting Infor-
mation.
2.2 PCR and quantitative real-time PCR
amplification of DNA target sequences
Isolation of Yersinia genomic DNA, as well as PCR and
quantitative real-time PCR of the locus tag identifier
YPO1670 was performed as described in the Supporting
Information.
2.3 RNA isolation and RT-PCR
Culturing of Y. pestis and Y. pseudotuberculosis for RNA analy-
sis and the methodology used for RNA isolation and RT-PCR
is detailed in the Supporting Information.
2.4 Production of recombinant YPO1670 protein
The recombinant YPO1670 protein was constructed with a
C-terminal hexahistidine tag using Y. pestis CO92 DNA as the
template and pET-30 (Novagen, Madison, WI, USA) as the
expression vector. Details of the cloning, expression, and pu-
rification procedures utilized are provided in the Supporting
Information. After purification and dialysis, the recombinant
YPO1670 protein was greater than 98% pure as determined
by 12% (w/v) SDS-PAGE analysis. Aliquots of the purified
recombinant protein were stored at 4C.
2.5 Antibody production and Western blot analysis
Procedures used for antibody production and Western blot
analysis are detailed in the Supporting Information.
2.6 Sample preparation for LTQ-Orbitrap MS and
data analysis
To prepare Yersinia proteins for LTQ-Orbitrap MS analysis,
the bacteria were cultured to stationary phase (22–24 h) in
brain-heart infusion (BHI) broth (Supporting Information
Fig. S1). Bacterial cells were then pelleted and resuspended
in chilled lysis buffer comprised of 50 mM Tris (pH 7.5),
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.clinical.proteomics-journal.com
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5% (v/v) glycerol, 200 mM NaCl, 0.1 mM PMSF, 0.1 mM
DTT, and EDTA-free protease inhibitors (Roche Applied Sci-
ence, Indianapolis, IN, USA). Cells were lysed in a Bead-
Beater (Biospec Products, Bartlesville, OK, USA) using a
50-mL chamber lined with ice and containing chilled 0.1-mm
glass beads. The recovered cell lysates were centrifuged for
1 h at 45 000 × g and 4C. To remove viable bacteria, cell
extracts were filtered through glass fiber prefilters and sterile
0.45 m acetate filters (Nalgene, Rochester, NY, USA). The
protein concentration in the filtrates was quantified using the
Bradford assay (Bio-Rad Laboratories, Hercules, CA, USA).
To enrich for the endogenous YPO1670 protein, ster-
ile Y. pestis supernatants were immunopurified using the
IgG mAbs F340–2 (14A3) and F340–3 (17E3) obtained in
this study. The antibody affinity column was prepared by
crosslinking 5.5 mg of IgG to 1 mL of agarose beads. After
loading the sterile supernatants onto the affinity column, the
captured proteins were eluted with glycine buffer (pH 2.5)
and fractionated by 12% (w/v) SDS-PAGE. The denaturing
gel was then stained with CBB G-250 and the proteins in the
size range of 36–38 kDa were excised. To prepare the pro-
teins for MS analysis, the excised proteins were reduced,
carbamidomethylated, and trypsin digested as previously
described [15].
The LTQ-Orbitrap XL mass spectrometer (Thermo Sci-
entific, San Jose, CA, USA) used for analysis of the Y. pestis
proteins was equippedwith an Eksigent nano-LC system. The
salt-free, trypsin-digested protein samples were loaded on a
PicoFrit C18 column-emitter (New Objective, Woburn, MA,
USA) that was equilibrated with 0.1% formic acid. Peptides
were eluted with a 60-min linear ACN gradient (0–60%) con-
taining 0.1% formic acid and then electrosprayed into the
LTQ-Orbitrap XL mass spectrometer. The LTQ-Orbitrap XL
mass spectrometer was operated in the data-dependent mode
to automatically switch betweenMS andMS/MS acquisition.
Survey full-scan MS spectra (from m/z 375 to 1575) were ac-
quired in the Orbitrap with resolution R = 100 000. Themost
intense ions (up to five, depending on signal intensity) were
sequentially isolated for fragmentation in the linear ion trap
using CID with normalized collision energy of 30% and a tar-
get value of 5000. Former target ions selected forMS/MSwere
dynamically excluded for 75 s. MS files were submitted to the
UNiquant software pipeline for peak list generation [16]. Pep-
tides and the associated proteins were identified in the open
access International Protein Index peak list using the Mascot
2.1.04 software package (Matrix Science, London, UK) [17].
2.7 Sample preparation for mass spectrometric
MRM analysis
Cell lysates ofY. pestiswere prepared forMRMMSby growing
the bacteria in BHI broth at 25C and 225 rpm. The bacterial
cells were pelleted after 22–24 h (OD600 = 5.5, Supporting
Information Fig. S1) and then resuspended in chilled lysis
buffer containing 50 mM Tris (pH 7.5), 5% (v/v) glycerol,
200 mM NaCl, 0.1 mM PMSF, 0.1 mM DTT, and
EDTA-free protease inhibitors (Roche Applied Science).
Lysis, centrifugation, and filtration to remove viable bacte-
ria were performed as described above, except that a 15-mL
chamber was used in the BeadBeater (Biospec Products) to
lyse the cells. Proteins in the extracts were separated by 12%
(w/v) SDS-PAGE and the presence of an antibody-reactive
37 kDa protein was confirmed byWestern blot analysis. After
CBB G-250 staining of the fractionated Y. pestis proteins, pro-
tein bands with a molecular mass of approximately 37 kDa
were excised. The gel slices containing Y. pestis proteins in
the 36–38 kDa range were reduced, carbamidomethylated,
and then digested with trypsin as previously described [15].
The MRM method used to detect and confirm the pres-
ence of the YPO1670 protein was developed by perform-
ing in silico analysis to predict the resulting trypsin di-
gested peptides and by utilizing LC-MS/MS of the trypsin
digested recombinant protein. Theoretical peptide masses
were calculated with the MS-Digest function in the Protein-
Prospector program developed by the University of Califor-
nia, San Francisco and directed by Dr. Alma Burlingame
(http://prospector.ucsf.edu/prospector/mshome.htm). For
analysis of the digested recombinant protein, the LTQ-
Orbitrap or Q-TRAP4000 hybrid triple quadrupole/linear ion
trapmass spectrometer (Applied Biosystems, Foster City, CA,
USA) was used. The identified peptides and MS/MS spectra
were then utilized to establish theMRMassay on theQ-TRAP
4000. Parent and daughter ionmasses used forMRManalysis
are listed in Table 1.
For the MRM assay, trypsin digested Y. pestis peptides
derived from the gel band were separated on an Eksigent
nanoflow LC system with a 75 m diameter × 150 mm long
C18 PepMap reversed-phase column (LC Packings, San Fran-
cisco, CA, USA). Elution of the peptides was achieved with a
90-min linear ACN gradient (2–60%) containing 0.1% formic
acid at a flow rate of 0.3 L/min. Peptides were then elec-
trosprayed into the Q-TRAP 4000 that was set to operate in
the MRMmode. MS source parameters were as follows: cap-
illary voltage, 1.8 kV; source temperature, 75C; and curtain
gas flow rate, 20 L/h. Nitrogen was used as curtain gas and
collision gas. Declustering, collision cell exit, and entrance
potentials were set at 75, 15, and 10 V, respectively. The dwell
time for each transition was 40 ms and the retention time
window was set at 5 min for every transition. The collision
energy and expected elution time for each precursor ion are
listed in Table 1.
MS data were acquired with Analyst software version 1.5
(AppliedBiosystems) and independent experimentswere per-
formed to validate reproducibility. The search engine Mascot
(Matrix Science) was used to determine the MOWSE score
for themass fingerprint obtained. TheMOWSE score is a sta-
tistical calculation that estimates the probability of a correct
identification, whereby the higher the score, the higher the
confidence level that the correct protein has been identified.
More specifically, a MOWSE score greater than 67 has a 95%
probability that the protein identification is correct.
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Table 1. MRM transitions for detecting hypothetical protein YPO1670 in the Y. pestis cell lysate
Peptide Parent Ion Daughter Ion Collision Elution
ion mass charge ion mass charge energy (V) time (min)
TPPFDSSR 453.4 y82+ 708.3 y61+ 28 17
TPPFDSSR 453.4 y82+ 611.3 y51+ 28 17
NLYC(CAM)EIDTRa) 592.3 y92+ 956.6 y71+ 34 22
NLYC(CAM)EIDTRa) 592.3 y92+ 793.3 y61+ 34 22
MoxDIFDFIDKb) 580.3 y92+ 784.4 y61+ 34 48
MoxDIFDFIDKb) 580.3 y92+ 522.4 y41+ 34 48
GQYEPLEYPR 626.3 y102+ 774.4 y61+ 36 15
GQYEPLEYPR 626.3 y102+ 1066.5 y81+ 36 15
IKPLEYYYPDK 714.9 y112+ 1187.6 y91+ 40 30
IKPLEYYYPDK 714.9 y112+ 977.2 y71+ 40 30
IGLETESYHLFFQQGK 949.0 y162+ 754.4 y61+ 44 51
IGLETESYHLFFQQGK 949.0 y162+ 892.4 y152+ 44 51
LAVENHEDETADEIIQIVK 722.7 y193+ 991.5 y172+ 44 25
LAVENHEDETADEIIQIVK 722.7 y193+ 957.6 y81+ 44 25
a) Carbamidomethylation of cysteine (CAM) added a mass of 57 daltons.
b) Oxidation of methionine (Mox) added a mass of 16 daltons.
3 Results
3.1 Experimental design and optimization of culture
conditions
The hypothesis tested in this study was that a combina-
tional approach targeting both chromosomal DNA and pro-
tein biomarkers unique to Y. pestis would reliably differen-
tiate this pathogen from closely related microbes such as Y.
pseudotuberculosis. To be considered a reliable biomarker, the
target must be stable and present throughout growth in all
strains of the pathogenic species of interest. Therefore, to de-
termine the impact of media, temperature, and the growth
phase of the bacteria on the targeted gene products presence
and abundance, experiments were performed using various
conditions and media. Bacterial growth was assessed in tryp-
tic soy broth (TSB), BHI, and RPMI 1640 with and without
aeration at 25C or 37C, temperatures reflecting that of a flea
or mammalian host, respectively.
Interestingly, Y. pestis grew in all three media, whereas
Y. pseudotuberculosis only grew in TSB and BHI (Supporting
Information Fig. S1). The highest cell densities obtained for
both bacterial species grown in either TSB or BHI occurred
when the cultures were aerated, with BHI providing fourfold
higher cell densities for Y. pestis (maximum OD600 = 5.5)
than TSB (maximum OD600 = 1.3) at 25C. Calcium sup-
plementation to TSB enhanced Y. pestis growth (maximum
OD600 = 2.0) as was previously reported [18], however, growth
was still threefold higher in BHI even without calcium sup-
plementation. Conversely, Y. pseudotuberculosis grew to high
cell densities in both TSB (maximum OD600 = 10.4 at 37C
and 6.7 at 25C) and BHI (maximum OD600 = 10.5 at 25C)
regardless of whether calcium was added or not.
Using the culturing conditions described in the Support-
ing Information section, Y. pestis and Y. pseudotuberculosis
entered stationary phase at 25C in TSB after 8 and 32 h,
respectively. At 37C in TSB, Y. pestis and Y. pseudotubercu-
losis entered stationary phase after 4 and 10 h, respectively.
When Y. pestis and Y. pseudotuberculosiswere cultured in BHI
at 25C, both bacteria entered stationary phase after approx-
imately 16–18 h. These results indicated that either TSB or
BHI could be used to propagate Y. pestis and Y. pseudotuber-
culosis. However, when higher cell densities of Y. pestis were
needed, BHI was the preferred medium.
3.2 In silico analysis of Y. pestis-specific genes
Computational analyses of chromosomal sequences available
for Y. pestis and Y. pseudotuberculosis revealed genes unique
to Y. pestis, one of which was identified as YPO1670 and
was predicted to encode a protein with a molecular mass of
37 kDa. Mining of the NCBI nonredundant 2011 database
using default parameters identified 45 records with differ-
ent accession numbers and indicated that all amino acid se-
quences were 100% identical to YPO1670 from the different
Y. pestis strains. Three different names were submitted for
this protein that included a putative L-xylulose-5-phosphate
3-epimerase, an AP endonuclease family 2, and a conserved
hypothetical protein.
Yersinia. pestis YPO1670 was chosen for further validation
for several reasons. Homology-based in silico analyses sug-
gested that this locus identifier encoded a 37 kDa cytosolic
protein that was unique to this pathogen. Therefore, analysis
of the endogenous and recombinant YPO167 protein would
be presumably less problematic than studying a hydropho-
bic membrane protein. The predicted size and composition
of the YPO1670 protein would provide a sufficient number
of trypsin-digested peptides and therefore, conclusively iden-
tify Y. pestis. The nucleotide sequence and transcript associ-
ated with this locus were noted by others to be present in
Y. pestis, but absent in Y. pseudotuberculosis [19, 20]. In ad-
dition, no other bacterial species contained this nucleotide
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.clinical.proteomics-journal.com
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Figure 1. Representative RT-PCR showing differential expression
of YPO1670 mRNA. Yersinia pestis RNA was analyzed using
YPO1670-specific primers after 3, 8, and 24 h of growth at 37C in
tryptic soy broth.
sequence, supporting our hypothesis that YPO1670 and the
products encoded by this locus would provide a Y. pestis-
specific biomarker.
3.3 PCR amplification and transcription of Y. pestis
YPO1670 locus
To confirm that the YPO1670 ORFwas unique to Y. pestis, the
presence of this DNA target in Y. pestis, Y. pseudotuberculosis,
and otherYersinia specieswas assessed. Initially, primers spe-
cific to the YPO1670 locus were utilized in PCR amplification
against an in-house collection of various Yersinia species that
includeY. enterocolitica, Y. frederiksenii, andY. rohdei (Support-
ing Information Table S1). Only theY. pestis strains examined
produced the expected 479 bp amplicon. For a more com-
prehensive analysis of the YPO1670 ORF, quantitative real-
time PCR was used to evaluate a large test panel of genomic
DNA extracted from numerous Y. pseudotuberculosis strains
(Supporting Information Table S1). These data demonstrated
that the chromosomal YPO1670 locus was unique to Y.
pestis and absent in other Yersinia species, including Y.
pseudotuberculosis.
Transcription of the YPO1670 ORF was evaluated by per-
forming RT-PCR with RNA extracted from Y. pestis and Y.
pseudotuberculosis grown in TSB after 3 h, 8 h, and 24 h at
37C. As shown in Fig. 1, Y. pestis mRNA associated with
the YPO1670 locus was observed at all three time points ex-
amined with the highest expression after 24 h of growth. In
contrast, no transcription of this gene was detected in Y. pseu-
dotuberculosis (data not shown). To verify that theRNA isolated
from Y. pseudotuberculosis was of high integrity, RT-PCR was
performed using primers for the Y. pseudotuberculosis-specific
gene mdoG. These reactions resulted in the expected 62 bp
product from extracted Y. pseudotuberculosis RNA, providing
additional evidence that the YPO1670 ORF is absent in this
species since the RNA isolated was of high quality. Together
Figure 2. Western blot analysis of recombinant and endogenous
Y. pestis YP1670. (A) Recombinant Y. pestis YP1670 at 5 ng (lane
1), 25 ng (lane 2), 50 ng (lane 3), and 100 ng (lane 4) was assessed
by Western blot analysis using polyclonal antiserum. (B) Whole
cell extracts from Y. pestis and Y. pseudotuberculosis grown in
brain-heart infusion at 25C were analyzed by Western blot analy-
sis using YPO1670-specific mAbs. Molecular mass markers (lane
1), Y. pestis cultured for 2 h (lane 2), Y. pseudotuberculosis cul-
tured for 2 h (lane 3), Y. pestis cultured for 24 h (lane 4), and Y.
pseudotuberculosis cultured for 24 h are shown.
these data, as well as the DNA sequencing results obtained
for the amplified products, confirmed that the YPO1670 locus
is unique to Y. pestis and transcriptionally expressed. More
importantly, these results demonstrated that the transcript
associated with YPO1670 is present throughout growth and
is most abundant during the stationary phase.
3.4 Western blot analysis detects Y. pestis-specific
YPO1670 protein
Although the gene and transcript corresponding to the
YPO1670 locus were exclusively detected in Y. pestis, Western
blot analysis was needed to determine if andwhen production
of the predicted 37 kDa protein occurred. To achieve this goal,
polyclonal antisera and mAbs were generated against pep-
tides and the recombinant protein derived from the predicted
YPO1670 ORF sequence. Results demonstrated that both the
polyclonal and YPO1670-specific mAbs had an LOD that was
approximately 5 ng (Fig. 2A and data not shown). Western
blot analyses using extracts of Y. pestis and Y. pseudotuber-
culosis grown in TSB or BHI at 25C demonstrated that the
37 kDaYPO1670 proteinwas exclusively expressed byY. pestis
throughout the growth cycle with the highest level of produc-
tion occurring during stationary phase (Fig. 2B, lanes 2 and
4), in agreement with transcript abundance (Fig. 1). Two faint
bands at approximately 36 kDa were observed for Y. pseudo-
tuberculosis that did not change in concentration throughout
growth and during stationary phase, suggesting that the anti-
bodies nonspecifically bound to these proteins (Fig. 2B, lanes
3 and 5). These findings supported the potential that the
Y. pestis YPO1670 protein may serve as a unique biomarker
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.clinical.proteomics-journal.com
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Clinical Relevance
Current DNA-based molecular assays are depend-
able when used in routine clinical applications, but
misidentification has occurred when assays were
challenged withmixtures of clinical and environmen-
tal samples. Due to the low prevalence of disease
caused by Yersinia pestis in industrialized countries,
even a highly specific test generates an unaccept-
able number of false-positive results. Further, dif-
ferentiation methods that focus on plasmid targets
within pathogens are unreliable since plasmids can
be eliminated. Therefore, next-generation assays for
the identification of infectious organisms are needed
to detect multiple signatures for improved specificity
based on species-specific chromosomal-derived tar-
gets with protein products. The goal of this project
was to utilize a combinational approach targeting
both chromosomal DNA and protein biomarkers to
reliably differentiate Y. pestis from closely relatedmi-
crobes such as Y. pseudotuberculosis. The study pre-
sented here validates a candidate chromosomal and
protein biomarker specific to Y. pestis using PCR and
MRM MS, respectively. This comprehensive strat-
egy can be applied to accurately distinguish other
pathogens from near neighbors that share consider-
able genomic content.
that is present throughout growth and during stationary
phase.
3.5 MS detects and confirms the identity of the
Y. pestis 37 kDa protein as YPO1670
AlthoughWestern blot analyses demonstrated reactivity with
the antibodies developed against the Y. pestis 37 kDa protein
target, the possibility remained that this was due to cross-
reactivity. Confirmation that the antibodies were specifically
binding to the YPO1670 protein was investigated byMS anal-
ysis of the immunoaffinity purified protein. Following 24 h
growth of Y. pestis in conditions that produced the highest
abundance of the 37 kDa protein based on Western blots
analyses, cell lysates were subjected to immunoaffinity chro-
matography. ThemAb-capturedproteinswere analyzedusing
the LTQ-Orbitrap MS instrument. Two independent experi-
ments identified the same Y. pestis peptide (LAVENHEDE-
TADEIIQIVK) using this MS method, which generated an
unambiguous match to YPO1670. These results confirm that
the 37 kDa protein detected and captured by the antibodies
was the Y. pestis YPO1670 protein and therefore, this target
protein is produced and unique to this pathogen.
A more sensitive proteomic-based methodology was
needed to detect and identify the endogenousY. pestis-specific
YPO1670 protein when present in whole cell lysates at biolog-
ical concentrations. The MRM MS methodology previously
described was selected for this purpose [21]. This approach
provides the ability to rapidly search for candidate peptides
obtained from the mass fingerprints that match with the tar-
get of interest. Twenty-eight pairs of parent and daughter
ions were included in the MRMmethod and 14 of these were
detected using a Q-TRAP 4000 mass spectrometer. Table 1
lists the 14 MRM transitions that gave positive results for
tryptic peptides of the YPO1670 protein and representative
positive hits for MRM transitions are shown in Fig. 3A in
which masses 580.3/522.4 and 580.3/784.4 were obtained. A
third MRM transition with masses 580.3/637.4 was also ac-
quired. A parent ion with an m/z equivalent to 580.3 eluted
at 50.1 min; this parent ion had daughter ions with an m/z
equal to 784.4 and 522.4. This MRM hit triggered acquisi-
tion of the representative fragmentation spectrum shown in
Fig. 3B. The y-ion series from y2 at 262.2 to y8 at 1012.7
supported the premise that the target protein contained the
Figure 3. Representative MRM transition and MS/MS spectrum
of a peptide detected in the trypsin digested cell lysate ofY. pestis.
(A) MRM detected two parent/daughter ion pairs corresponding
to theoretical masses for peptide MoxDIFDFIDK, where Mox indi-
cates oxidized methionine. (B) The MS/MS spectrum of the dou-
bly charged parent ion with an m/z equivalent to 580.4 yielded
fragment ions whose masses support the sequence MoxDIFD-
FIDK, a peptide in the Y. pestis YPO1670 protein.
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.clinical.proteomics-journal.com
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Figure 4. Yersinia pestis YPO1670 protein sequence. Peptides in
bold letters were identified in the Y. pestis cell lysate byMS using
MRM.
peptide sequence MoxDIFDFIDK, where Mox indicates oxi-
dizedmethionine. As expected from the results shown in Fig.
3A, the y6 ion at 784.6 Da and the y4 ion at 522.7 Da were
both present in Fig. 3B. The peak intensity of y6 was higher
than that of y4, concurring with the relative peak heights of
these ions shown in Fig. 3A. The MS/MS spectra for the six
additional peptides identifying the YPO1670 protein and the
MRM chromatographic profiles are shown in the Supporting
Information section. Figure 4 shows the protein sequence for
YPO1670 and the seven peptides identified by MRM MS.
Overall, MRM MS identified the target YPO1670 from a
Y. pestis extract, confirming the ability to detect this unique
protein at biological concentrations. Out of 328 amino acids,
82 were identified in seven peptides with a MOWSE score of
1101, indicating high confidence in the identity of the 37 kDa
protein as YPO1670. Although two peptides are typically suf-
ficient to confidently identify a protein usingMRMMS, seven
matching peptides were reproducibly obtained, covering 25%
of the YPO1670 protein.
4 Discussion
The capability for acquisition of multidrug resistance in Y.
pestis [22], and the ease at which this highly virulent pathogen
can be transmitted by arthropods or infected mammals
emphasizes the importance of this select agent pathogen.
Since the prevalence of plague is low, even assays with excel-
lent sensitivity and specificity will have a relatively high false-
positive rate. Combinational approaches that utilize both
DNA and protein targets into one assay may improve diag-
nostic accuracy. To achieve this goal, the temporal expression
of targeted gene products and the stability of the differentiat-
ing biomarkers must be considered. Yersinia pestis presents
a special problem since many DNA targets used in current
assays are located on plasmids that may be lost or transferred
to other bacterial species. Further, the difficulty in acquiring
mAbs with high specificity to a target protein makes reliable
immunological assays arduous and costly to develop. There-
fore, in contrast to PCR- and antibody-based assays, which
comprise the majority of the current methodologies, the use
of MRM MS to identify species-specific protein biomarkers
is less likely to incur cross-contamination issues and back-
ground problems, respectively.
A comparison of 59 Y. pestis and 39 Y. pseudotuberculosis
genome sequences identified eight chromosomal loci specific
toY. pestis, one ofwhich included theYPO1670gene [23]. Each
Y. pestis-specific loci was individually deleted and the result-
ing mutant strain was fed to fleas via a blood meal or used
to infect mice [23]. The data obtained from these mutational
analyses showed that none of these unique genes contributed
to virulence by itself, since no differences were noted com-
pared to wild-type Y. pestis. Carniel and associates proposed
three possible explanations for their findings. (i) The deletion
of several or multiple genes was needed to impair virulence,
(ii) the extreme pathogenicity of this microbe in the mouse
model obscured minor virulence defects, and/or (iii) these
acquired loci may participate in the long-term persistence of
this pathogen outside of an insect vector or mammalian host.
However, for a more complete analysis of gene function, ad-
ditional studies are needed to determine whether these Y.
pestis-specific loci produce a protein product.
Although previous studies have identified proteins ex-
pressed by Y. pestis, no comparison was made to the pro-
teome of Y. pseudotuberculosis [24–26]. Therefore, YPO1670
appears to be the first confirmed chromosomally encoded
protein unique to Y. pestis. Identification of Y. pestis-specific
chromosomally encoded proteins by a proteomic approach is
difficult, since the target proteins may require special con-
ditions for expression and/or are produced at low levels for
a brief period of time. The studies described here provide
evidence that the YPO1670 protein is expressed exclusively
by Y. pestis, but not the closest relative Y. pseudotuberculo-
sis. Further, the production of the Y. pestis YPO1670 protein
throughout growth and especially during stationary phase
supports the premise that this protein would serve as a re-
liable candidate biomarker for this pathogen. As a result of
these studies, the hypothetical protein associated with the lo-
cus tag YPO1670 in the Yersinia database has been updated
to be annotated as an expressed Y. pestis protein.
This study provided proof of concept that species-specific
proteins can be used as biomarkers to distinguish closely re-
lated microbes within a mixture of other proteins. MRM MS
proteomic profiling can also provide insight into the patho-
physiological status of the host by the detection of disease-
specific biomarkers, unique protein/peptide patterns, and/or
protein modifications. MS/MS analysis of intact proteins
has even identified misannotated sequences and suggested
homology-based classification of microbes with no or limited
sequence information [27]. We anticipate that the dual use
of DNA and protein biomarkers has utility in the future for
pathogen identification in both clinical and field applications.
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